Chiesi Global Launches ‘Rethink Fabry’ Campaign With New Resources, Website

Chiesi Global Launches ‘Rethink Fabry’ Campaign With New Resources, Website
0
(0)

Chiesi Global Rare Diseases has launched a campaign called “Rethink Fabry” that seeks to help people with the rare genetic disorder, along with their caregivers and family members, to make informed healthcare decisions.

The Italian pharmaceutical’s “disease education program,” currently intended for U.S. residents only, also includes new resources for healthcare professionals to support the diagnosis and management of Fabry disease.

“As with any rare disease, working to build broader awareness of Fabry disease and providing patients, caregivers, and healthcare providers with the information they need to make informed decisions is an important and ongoing need. Chiesi Global Rare Diseases is deeply committed to working with all members of the Fabry community to achieve this goal,” Giacomo Chiesi, head of Chiesi Global, said in a press release.

“The patients are the beginning and end of our journey, and our Rethink Fabry campaign will provide them with many new resources and insights to help them make optimal decisions about their health,” Chiesi said.

The campaign aims to call broader attention to Fabry and its symptoms, as well as the impact the disease has on the everyday lives of patients and their families. With its new website, the program also emphasizes areas of unmet need in patient care and the time it takes individuals with the disease to get a diagnosis.

In its section on “The Hidden Impact of Fabry Disease,” this patient webpage points out that some daily symptoms, including pain and gastrointestinal issues, can affect daily life, even when the disease is thought to be under control.

Long-term disease challenges also are addressed, particularly Fabry’s impact, despite treatment, on the kidneys, heart, and brain.

The website also offers a free webinar series, featuring patients and Fabry experts, that will provide information and guidance to those with the disease. Registration in these webinars, which are intended only for those living in the U.S., may be completed here.

Chiese Global’s program also explores the benefits that can come with a greater awareness of the challenges faced by people living with Fabry, potentially including more proactive, informed, and advanced care.

Finally, the campaign offers a downloadable resource to help facilitate conversations between patients and their healthcare team. The guide can help patients understand the risks of disease progression, establish their healthcare team, and learn how to better manage Fabry.

The program’s additional webpage for healthcare professionals discusses unmet needs in Fabry, as well as treatments, disease management, and diagnosis. It also has information about lesser-known symptoms among treated patients, including kidney function decline and neurological issues.

Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Total Posts: 24
Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.
×
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Latest Posts
  • fatigue in Fabry disease
  • Rethink Fabry, Chiesi Global
  • Rethink Fabry, Chiesi Global

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?